Narendra Investment (Delhi) Limited enters into slump sale agreement with Urvi Speciality Chemicals
Posted On: 2021-03-01 10:57:47 (Time Zone: Arizona, USA)
The Board of Directors of Narendra Investment (Delhi) Limited ( The Company ) at its meeting held today commenced at 11.30 am and concluded at 7.15 pm has approved and taken on record the in-principal approval letter dated February 26, 2021 received from Registrar of Companies, Central Registration Centre, reserving the change of name from NARENDRA INVESTMENTS (DELHI) LIMITED to EIKO LIFE SCIENCES LIMITED .
The board approved raising of funds by issue of securities on preferential basis, subject to necessary shareholders / regulatory approvals, as applicable. The Board of Directors, at its meeting held today, has taken note of the investors who have individually expressed their agreement / willingness to subscribe upto 24,29,967 Equity Shares of Rs. 10/- each, being issued at a price of Rs. 30/- per share including R